ALKERMES reported 0 in Dividend Yield for its fiscal quarter ending in March of 2025.





Dy Change Date
AbbVie 3.1 0.19 Mar/2026
Amgen 2.78 0.17 Mar/2026
Bristol-Myers Squibb 4.12 3.9 Mar/2026
Coherus Biosciences 0 0 Mar/2025
Eli Lilly 0.58 0.16 Dec/2025
Gilead Sciences 2.29 0.29 Mar/2026
Heron Therapeutics 0 0 Mar/2025
J&J 2.16 0.34 Mar/2026
Merck 2.76 0.36 Mar/2026
Minerva Neurosciences 0 0 Mar/2025
Nektar Therapeutics 0 0 Mar/2025
Otsuka Holdings 1.27 0.19 Mar/2026
Pfizer 6.36 0.55 Mar/2026
Regeneron Pharmaceuticals 0.46 0.01 Mar/2026